PETER J PANZARINO
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry
- Where
- MONTICELLO, NY
- NPI
- 1093798928
- Received
- $13,490 in 650 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 108 | $2,441 |
| 2024 | General payment | 121 | $3,139 |
| 2023 | General payment | 97 | $2,272 |
| 2022 | General payment | 121 | $2,238 |
| 2021 | General payment | 105 | $1,794 |
| 2020 | General payment | 54 | $942 |
| 2019 | General payment | 44 | $662 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| ABBVIE INC. | 137 | $3,417 | 2021–2025 |
| Teva Pharmaceuticals USA, Inc. | 102 | $1,856 | 2019–2025 |
| Janssen Pharmaceuticals, Inc | 65 | $1,156 | 2019–2025 |
| Otsuka America Pharmaceutical, Inc. | 45 | $1,016 | 2019–2025 |
| Neuronetics, Inc. | 24 | $902 | 2019–2025 |
| Sunovion Pharmaceuticals Inc. | 59 | $779 | 2019–2022 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 38 | $764 | 2020–2025 |
| Neurocrine BioSciences, Inc. | 33 | $738 | 2019–2025 |
| Alkermes, Inc. | 31 | $611 | 2019–2025 |
| Axsome Therapeutics, Inc. | 20 | $515 | 2023–2025 |
| Supernus Pharmaceuticals, Inc. | 27 | $375 | 2021–2023 |
| Indivior Inc. | 9 | $220 | 2022–2025 |
| Orexo US, Inc. | 10 | $187 | 2022–2025 |
| Allergan, Inc. | 9 | $181 | 2019–2020 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $119 | 2019–2024 |
| Eisai Inc. | 7 | $116 | 2020–2021 |
| Braeburn Inc. | 6 | $116 | 2024–2025 |
| E.R. Squibb & Sons, L.L.C. | 4 | $81 | 2025 |
| Vanda Pharmaceuticals Inc. | 3 | $81 | 2025 |
| Corium, LLC | 4 | $59 | 2022–2023 |
| JAZZ PHARMACEUTICALS INC. | 3 | $54 | 2021 |
| Biogen, Inc. | 2 | $53 | 2024 |
| IDORSIA PHARMACEUTICALS US INC | 2 | $31 | 2022–2023 |
| IRONSHORE PHARMACEUTICALS INC. | 1 | $17 | 2024 |
| Sage Therapeutics, LLC | 1 | $17 | 2020 |
| Avanir Pharmaceuticals, Inc. | 1 | $16 | 2019 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 647 | $13,323 |
| Education | 3 | $167 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-19 | Teva Pharmaceuticals USA, Inc. | $13 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-12-09 | Janssen Pharmaceuticals, Inc | $21 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-12-08 | Neurocrine BioSciences, Inc. | $29 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-11-20 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-20 | Teva Pharmaceuticals USA, Inc. | $20 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-11-12 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-10 | Teva Pharmaceuticals USA, Inc. | $19 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-11-06 | Otsuka America Pharmaceutical, Inc. | $14 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-11-06 | Otsuka America Pharmaceutical, Inc. | $2 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-11-03 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-30 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-29 | Axsome Therapeutics, Inc. | $21 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-10-29 | Teva Pharmaceuticals USA, Inc. | $7 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-10-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-24 | Braeburn Inc. | $16 | Food and Beverage | In-kind items and services | BRIXADI Drug, Opioid Use Disorder | 2025 | |
| 2025-10-22 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-22 | Teva Pharmaceuticals USA, Inc. | $5 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-10-20 | ABBVIE INC. | $125 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-08 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-01 | Teva Pharmaceuticals USA, Inc. | $8 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-09-29 | Braeburn Inc. | $18 | Food and Beverage | In-kind items and services | BRIXADI Drug, Opioid Use Disorder | 2025 | |
| 2025-09-24 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-24 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-17 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-09-15 | Alkermes, Inc. | $18 | Food and Beverage | In-kind items and services | VIVITROL Drug, CNS | 2025 | |
| 2025-09-15 | Otsuka America Pharmaceutical, Inc. | $7 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-09-09 | Teva Pharmaceuticals USA, Inc. | $124 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-09-05 | ABBVIE INC. | $0 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-27 | Neurocrine BioSciences, Inc. | $34 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-25 | Teva Pharmaceuticals USA, Inc. | $24 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-25 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-21 | Axsome Therapeutics, Inc. | $19 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-08-18 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-13 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-07 | E.R. Squibb & Sons, L.L.C. | $20 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-08-06 | Otsuka America Pharmaceutical, Inc. | $17 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-31 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-24 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-23 | Axsome Therapeutics, Inc. | $16 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-07-21 | Teva Pharmaceuticals USA, Inc. | $11 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-07-17 | Vanda Pharmaceuticals Inc. | $25 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-07-10 | Orexo US, Inc. | $24 | Food and Beverage | Cash or cash equivalent | Zubsolv Drug, Addiction Medicine | 2025 | |
| 2025-07-09 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-03 | Teva Pharmaceuticals USA, Inc. | $23 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-06-30 | ABBVIE INC. | $11 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-26 | Otsuka America Pharmaceutical, Inc. | $24 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-25 | Otsuka America Pharmaceutical, Inc. | $4 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2025 | |
| 2025-06-23 | ABBVIE INC. | $33 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-20 | ABBVIE INC. | $1 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-18 | Janssen Pharmaceuticals, Inc | $17 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-06-12 | Vanda Pharmaceuticals Inc. | $24 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-06-12 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-05 | Indivior Inc. | $16 | Food and Beverage | In-kind items and services | SUBLOCADE Drug, OUD | 2025 | |
| 2025-06-04 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-06-02 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-06-02 | Neuronetics, Inc. | $17 | Food and Beverage | Cash or cash equivalent | NEUROSTAR TMS THERAPY SYSTEM Device, NEUROSTAR TMS THERAPY SYSTEM | 2025 | |
| 2025-05-30 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-29 | Axsome Therapeutics, Inc. | $21 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-05-28 | Teva Pharmaceuticals USA, Inc. | $28 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-05-21 | Teva Pharmaceuticals USA, Inc. | $30 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-05-21 | Janssen Pharmaceuticals, Inc | $19 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-05-20 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-16 | Neuronetics, Inc. | $7 | Food and Beverage | Cash or cash equivalent | NEUROSTAR TMS THERAPY SYSTEM Device, NEUROSTAR TMS THERAPY SYSTEM | 2025 | |
| 2025-05-13 | E.R. Squibb & Sons, L.L.C. | $23 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-05-08 | Axsome Therapeutics, Inc. | $17 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-05-05 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-05-02 | Teva Pharmaceuticals USA, Inc. | $111 | Education | In-kind items and services | 2025 | ||
| 2025-05-01 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $14 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-04-29 | Indivior Inc. | $21 | Food and Beverage | In-kind items and services | SUBLOCADE Drug, OUD | 2025 | |
| 2025-04-26 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-24 | Teva Pharmaceuticals USA, Inc. | $22 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-04-22 | Alkermes, Inc. | $32 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2025 | |
| 2025-04-07 | Otsuka America Pharmaceutical, Inc. | $28 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-04-04 | Vanda Pharmaceuticals Inc. | $31 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-03-31 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-03-28 | Teva Pharmaceuticals USA, Inc. | $24 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-03-27 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-13 | Indivior Inc. | $17 | Food and Beverage | In-kind items and services | SUBLOCADE Drug, OUD | 2025 | |
| 2025-03-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-03-10 | ABBVIE INC. | $33 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-06 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-06 | Teva Pharmaceuticals USA, Inc. | $3 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-03-04 | Teva Pharmaceuticals USA, Inc. | $22 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-02-27 | Otsuka America Pharmaceutical, Inc. | $20 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-02-26 | Janssen Pharmaceuticals, Inc | $17 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-02-22 | Neuronetics, Inc. | $7 | Food and Beverage | Cash or cash equivalent | NEUROSTAR TMS THERAPY SYSTEM Device, NEUROSTAR TMS THERAPY SYSTEM | 2025 | |
| 2025-02-14 | Braeburn Inc. | $22 | Food and Beverage | In-kind items and services | BRIXADI Drug, Opioid Use Disorder | 2025 | |
| 2025-02-12 | Teva Pharmaceuticals USA, Inc. | $26 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-02-12 | Janssen Pharmaceuticals, Inc | $17 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-02-12 | E.R. Squibb & Sons, L.L.C. | $16 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-02-07 | Neurocrine BioSciences, Inc. | $29 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-02-05 | ABBVIE INC. | $125 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-29 | Indivior Inc. | $19 | Food and Beverage | In-kind items and services | SUBLOCADE Drug, OUD | 2025 | |
| 2025-01-28 | Teva Pharmaceuticals USA, Inc. | $26 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-01-28 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-27 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-24 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-01-23 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-21 | Neurocrine BioSciences, Inc. | $26 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-13 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-10 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-10 | Teva Pharmaceuticals USA, Inc. | $5 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2025 | |
| 2025-01-09 | Otsuka America Pharmaceutical, Inc. | $20 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-01-07 | Neurocrine BioSciences, Inc. | $25 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-06 | Otsuka America Pharmaceutical, Inc. | $16 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-01-06 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-03 | E.R. Squibb & Sons, L.L.C. | $21 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2024-12-19 | ABBVIE INC. | $31 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-12-19 | Teva Pharmaceuticals USA, Inc. | $5 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-12-17 | Neurocrine BioSciences, Inc. | $25 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-12-12 | Janssen Pharmaceuticals, Inc | $24 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-12-12 | Janssen Pharmaceuticals, Inc | $1 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-12-09 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-12-02 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-11-21 | Teva Pharmaceuticals USA, Inc. | $28 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-11-19 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-11-15 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $26 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-11-13 | Teva Pharmaceuticals USA, Inc. | $25 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-11-12 | Neuronetics, Inc. | $7 | Food and Beverage | Cash or cash equivalent | NEUROSTAR TMS THERAPY SYSTEM Device, NEUROSTAR TMS THERAPY SYSTEM | 2024 | |
| 2024-11-12 | Neuronetics, Inc. | $3 | Food and Beverage | Cash or cash equivalent | NEUROSTAR TMS THERAPY SYSTEM Device, NEUROSTAR TMS THERAPY SYSTEM | 2024 | |
| 2024-11-07 | Takeda Pharmaceuticals U.S.A., Inc. | $18 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-11-05 | Janssen Pharmaceuticals, Inc | $17 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-10-31 | Teva Pharmaceuticals USA, Inc. | $2 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-10-23 | Neuronetics, Inc. | $12 | Food and Beverage | Cash or cash equivalent | NEUROSTAR TMS THERAPY SYSTEM Device, NEUROSTAR TMS THERAPY SYSTEM | 2024 | |
| 2024-10-22 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-10-17 | Orexo US, Inc. | $13 | Food and Beverage | Cash or cash equivalent | Zubsolv Drug, Addiction Medicine | 2024 | |
| 2024-10-15 | Janssen Pharmaceuticals, Inc | $16 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-10-08 | Neuronetics, Inc. | $30 | Food and Beverage | Cash or cash equivalent | NEUROSTAR TMS THERAPY SYSTEM Device, NEUROSTAR TMS THERAPY SYSTEM | 2024 | |
| 2024-10-08 | Neuronetics, Inc. | $30 | Food and Beverage | Cash or cash equivalent | NEUROSTAR TMS THERAPY SYSTEM Device, NEUROSTAR TMS THERAPY SYSTEM | 2024 | |
| 2024-10-03 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-10-03 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-09-26 | Braeburn Inc. | $24 | Food and Beverage | In-kind items and services | BRIXADI Drug, Opioid Use Disorder | 2024 | |
| 2024-09-23 | Axsome Therapeutics, Inc. | $23 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-09-19 | ABBVIE INC. | $30 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-09-19 | Teva Pharmaceuticals USA, Inc. | $4 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-09-19 | Teva Pharmaceuticals USA, Inc. | $3 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-09-18 | Janssen Pharmaceuticals, Inc | $22 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-09-10 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-09-09 | Neuronetics, Inc. | $20 | Food and Beverage | Cash or cash equivalent | NEUROSTAR TMS THERAPY SYSTEM Device, NEUROSTAR TMS THERAPY SYSTEM | 2024 | |
| 2024-09-09 | Neuronetics, Inc. | $4 | Food and Beverage | Cash or cash equivalent | NEUROSTAR TMS THERAPY SYSTEM Device, NEUROSTAR TMS THERAPY SYSTEM | 2024 | |
| 2024-09-04 | Neuronetics, Inc. | $20 | Food and Beverage | Cash or cash equivalent | NEUROSTAR TMS THERAPY SYSTEM Device, NEUROSTAR TMS THERAPY SYSTEM | 2024 | |
| 2024-08-28 | Alkermes, Inc. | $28 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-08-28 | Teva Pharmaceuticals USA, Inc. | $4 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-08-23 | Janssen Pharmaceuticals, Inc | $23 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-08-23 | Janssen Pharmaceuticals, Inc | $3 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-08-22 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-08-21 | Neuronetics, Inc. | $45 | Food and Beverage | Cash or cash equivalent | NEUROSTAR TMS THERAPY SYSTEM Device, NEUROSTAR TMS THERAPY SYSTEM | 2024 | |
| 2024-08-20 | Axsome Therapeutics, Inc. | $17 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-08-09 | Neuronetics, Inc. | $35 | Food and Beverage | Cash or cash equivalent | NEUROSTAR TMS THERAPY SYSTEM Device, NEUROSTAR TMS THERAPY SYSTEM | 2024 | |
| 2024-08-07 | Braeburn Inc. | $17 | Food and Beverage | In-kind items and services | BRIXADI Drug, Opioid Use Disorder | 2024 | |
| 2024-08-05 | Indivior Inc. | $33 | Food and Beverage | In-kind items and services | SUBLOCADE Drug, OUD | 2024 | |
| 2024-08-01 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $10 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-08-01 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-07-30 | Axsome Therapeutics, Inc. | $18 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-07-30 | Neuronetics, Inc. | $2 | Food and Beverage | Cash or cash equivalent | NEUROSTAR TMS THERAPY SYSTEM Device, NEUROSTAR TMS THERAPY SYSTEM | 2024 | |
| 2024-07-29 | Orexo US, Inc. | $16 | Food and Beverage | Cash or cash equivalent | Zubsolv Drug, Addiction Medicine | 2024 | |
| 2024-07-25 | Alkermes, Inc. | $20 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-07-24 | Neuronetics, Inc. | $35 | Food and Beverage | Cash or cash equivalent | NEUROSTAR TMS THERAPY SYSTEM Device, NEUROSTAR TMS THERAPY SYSTEM | 2024 | |
| 2024-07-24 | Janssen Pharmaceuticals, Inc | $21 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-07-18 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-07-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $17 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-07-15 | Teva Pharmaceuticals USA, Inc. | $6 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-07-11 | Biogen, Inc. | $27 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-07-09 | Braeburn Inc. | $17 | Food and Beverage | In-kind items and services | BRIXADI Drug, Opioid Use Disorder | 2024 | |
| 2024-06-27 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-06-25 | Takeda Pharmaceuticals U.S.A., Inc. | $24 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-06-24 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-18 | Alkermes, Inc. | $26 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-06-10 | Axsome Therapeutics, Inc. | $24 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-06-05 | Alkermes, Inc. | $20 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-06-04 | Alkermes, Inc. | $27 | Food and Beverage | In-kind items and services | VIVITROL Drug, CNS | 2024 | |
| 2024-06-04 | Janssen Pharmaceuticals, Inc | $19 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-06-01 | Neuronetics, Inc. | $21 | Food and Beverage | Cash or cash equivalent | NEUROSTAR TMS THERAPY SYSTEM Device, NEUROSTAR TMS THERAPY SYSTEM | 2024 | |
| 2024-05-31 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-30 | Otsuka America Pharmaceutical, Inc. | $15 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2024 | |
| 2024-05-30 | Teva Pharmaceuticals USA, Inc. | $5 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-05-29 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-21 | Teva Pharmaceuticals USA, Inc. | $28 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2024 | |
| 2024-05-17 | ABBVIE INC. | $29 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-14 | Teva Pharmaceuticals USA, Inc. | $17 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-05-08 | Alkermes, Inc. | $29 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-05-06 | Neuronetics, Inc. | $50 | Food and Beverage | Cash or cash equivalent | NEUROSTAR TMS THERAPY SYSTEM Device, NEUROSTAR TMS THERAPY SYSTEM | 2024 | |
| 2024-05-03 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-04-30 | Janssen Pharmaceuticals, Inc | $24 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-04-30 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-04-26 | ABBVIE INC. | $28 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-04-19 | ABBVIE INC. | $31 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-04-17 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-04-12 | Neuronetics, Inc. | $157 | Food and Beverage | Cash or cash equivalent | NEUROSTAR TMS THERAPY SYSTEM Device, NEUROSTAR TMS THERAPY SYSTEM | 2024 | |
| 2024-04-12 | Neuronetics, Inc. | $157 | Food and Beverage | Cash or cash equivalent | NEUROSTAR TMS THERAPY SYSTEM Device, NEUROSTAR TMS THERAPY SYSTEM | 2024 | |
| 2024-04-09 | Janssen Pharmaceuticals, Inc | $23 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-04-05 | Neuronetics, Inc. | $53 | Food and Beverage | Cash or cash equivalent | NEUROSTAR TMS THERAPY SYSTEM Device, NEUROSTAR TMS THERAPY SYSTEM | 2024 | |
| 2024-04-05 | Neuronetics, Inc. | $53 | Food and Beverage | Cash or cash equivalent | NEUROSTAR TMS THERAPY SYSTEM Device, NEUROSTAR TMS THERAPY SYSTEM | 2024 | |
| 2024-04-05 | Neuronetics, Inc. | $49 | Food and Beverage | Cash or cash equivalent | NEUROSTAR TMS THERAPY SYSTEM Device, NEUROSTAR TMS THERAPY SYSTEM | 2024 | |
| 2024-04-05 | Neuronetics, Inc. | $49 | Food and Beverage | Cash or cash equivalent | NEUROSTAR TMS THERAPY SYSTEM Device, NEUROSTAR TMS THERAPY SYSTEM | 2024 | |
| 2024-04-05 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-04-03 | Biogen, Inc. | $25 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-03-29 | ABBVIE INC. | $23 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-03-29 | Takeda Pharmaceuticals U.S.A., Inc. | $19 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 |
The latest 200 records of 650.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Monticello, NY, county Sullivan County, NY, state New York; placed by its city name.
| Measure | Place (city or town) Monticello, NY | County Sullivan County, NY | State New York |
|---|---|---|---|
| Population B01003 | 7,279 | 79,721 | 19,852,366 |
| Population, 2020 census P1 | 7,173 | 78,624 | 20,201,249 |
| Median age B01002 | 35.9 | 41.7 | 39.8 |
| Under 18 B01001 | 22.3% | 21.4% | 20.5% |
| 65 and over B01001 | 16.3% | 19.3% | 17.9% |
| Households B11001 | 3,040 | 31,434 | 7,722,646 |
| Foreign born B05002 | 23.4% | 13.0% | 22.8% |
| Median household income B19013 | $50,583 | $72,382 | $85,974 |
| Median family income B19113 | $58,569 | $92,132 | $106,873 |
| Per capita income B19301 | $26,244 | $42,334 | $50,712 |
| Poverty rate B17001 | 29.7% | 15.9% | 14.0% |
| Unemployment rate B23025 | 8.6% | 5.8% | 6.4% |
| Civilian labor force B23025 | 3,548 | 37,967 | 10,171,766 |
| Mean commute (minutes) B08013 | 21.5 | 28.0 | 32.6 |
| Bachelor's degree or higher B15003 | 12.1% | 30.1% | 40.2% |
| Housing units B25001 | 3,718 | 49,994 | 8,585,241 |
| Owner-occupied B25003 | 20.1% | 67.4% | 54.3% |
| Renters B25003 | 79.9% | 32.6% | 45.7% |
| Median home value B25077 | $172,000 | $249,000 | $423,800 |
| Median gross rent B25064 | $1,166 | $1,106 | $1,621 |
| White, not Hispanic B03002 | 28.7% | 66.0% | 52.8% |
| Black B03002 | 24.5% | 8.4% | 13.4% |
| Hispanic or Latino B03002 | 37.1% | 19.0% | 19.8% |
| Asian B03002 | 4.6% | 2.1% | 9.0% |
| American Indian and Alaska Native B03002 | 0.0% | 0.2% | 0.2% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Monticello, NY.
Comments